or
forgot password
  • cancer clinical trials in arkansas

  • Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    Hembree Mercy Cancer Center at St. Edward Mercy Medical Center

    Trial Locations
    Hembree Mercy Cancer Center at St. Edward Mercy Medical Center
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Saint Joseph's Mercy Cancer Center

    Trial Locations
    Saint Joseph's Mercy Cancer Center
    Saint Bernards Regional Medical Center
    NEA Baptist Memorial Hospital
    University of Arkansas for Medical Sciences
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Little Rock, Arkansas 72205
    Breast Cancer
    Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
    Heritage Physicians Group Oncology

    Trial Locations
    Heritage Physicians Group Oncology
    The Center for Chest Care
    Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Saint Bernards Regional Medical Center

    Trial Locations
    Saint Bernards Regional Medical Center
    NEA Baptist Memorial Hospital
    NEA Baptist Clinic-Matthews
    University of Arkansas for Medical Sciences
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Saint Joseph's Mercy Cancer Center

    Trial Locations
    Saint Joseph's Mercy Cancer Center
    University of Arkansas for Medical Sciences
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
    Saint Bernards Regional Medical Center

    Trial Locations
    Saint Bernards Regional Medical Center
    University of Arkansas for Medical Sciences
    Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer, Large Cell Lung Cancer, Squamous Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer
    S0530 Cytarabine and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Leukemia
    Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Extraskeletal Osteosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Malignant Fibrous Histiocytoma, Adult Malignant Hemangiopericytoma, Adult Malignant Mesenchymoma, Adult Neurofibrosarcoma, Adult Synovial Sarcoma, Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Malignant Mesenchymoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans, Localized Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer
    GSK Investigational Site
    Little Rock, Arkansas 72205
    Neoplasms, Breast
    Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Childhood Malignant Mesenchymoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Leukemia, Myelodysplastic Syndromes
    Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Leukemia
    S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Lymphoma
    A Rollover Study for Patients Who Received CP-675,206 in Other Protocols, to Allow the Patients Access to CP-675,206 Until This Agent Becomes Commercially Available or Development is Discontinued.
    Research Site
    Bentonville, Arkansas
    Colorectal Neoplasms, Melanoma, Prostatic Neoplasms, Renal Cell Carcinoma, Neoplasms, Patients Who Have/Have Had Melanoma and Other Tumors
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Saint Edward Mercy Medical Center

    Trial Locations
    Saint Edward Mercy Medical Center
    NEA Baptist Memorial Hospital
    University of Arkansas for Medical Sciences
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Breast Cancer
    First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX
    Research Site
    Bentonville, Arkansas
    Colorectal Cancer
    Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer
    GSK Investigational Site
    Little Rock, Arkansas 72205
    Lung Cancer, Non-Small Cell
    Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Untreated Childhood Medulloblastoma, Untreated Childhood Pineoblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Breast Cancer
    Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer
    Saint Edward Mercy Medical Center
    Ft. Smith, Arkansas 72903
    Non-small Cell Lung Cancer
    An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer
    Research Site
    Bentonville, Arkansas
    Thyroid Cancer
    S0622, Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences

    Trial Locations
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Highlands Oncology Group - Springdale
    Breast Cancer, Metastatic Cancer
    Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Bladder Cancer
    PARTNER: Panitumumab Added to Regimen for Treatment of Head aNd Neck Cancer Evaluation of Response
    Research Site
    Bentonville, Arkansas
    Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck
    Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Ototoxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Trial of Dasatinib in Advanced Sarcomas
    Arkansas Children's Hospital
    Little Rock, Arkansas 72202-3591
    Rhabdomyosarcoma, Malignant Peripheral Nerve Sheath Tumors, Chondrosarcoma, Sarcoma, Ewing's, Sarcoma, Alveolar Soft Part, Chordoma, Epithelioid Sarcoma, Giant Cell Tumor of Bone, Hemangiopericytoma, Gastrointestinal Stromal Tumor (GIST)
    Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer, Testicular Germ Cell Tumor
    A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
    University of Arkansas for Medical Sciences

    Trial Locations
    University of Arkansas for Medical Sciences
    Hull Dermatology, P.A.
    Atopic Dermatitis
    Arginine Feeding: a Novel Strategy to Improve Protein Metabolism in Cancer and the Response to Surgery
    University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Protein Metabolism
    Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
    Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
    Little Rock, Arkansas 72205
    Lung Cancer
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Saint Edward Mercy Medical Center
    Ft. Smith, Arkansas 72903
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer